NO20076463L - Synergetiske kombinasjoner - Google Patents
Synergetiske kombinasjonerInfo
- Publication number
- NO20076463L NO20076463L NO20076463A NO20076463A NO20076463L NO 20076463 L NO20076463 L NO 20076463L NO 20076463 A NO20076463 A NO 20076463A NO 20076463 A NO20076463 A NO 20076463A NO 20076463 L NO20076463 L NO 20076463L
- Authority
- NO
- Norway
- Prior art keywords
- combinations
- synergetic
- synergetic combinations
- pregabalin
- carprofen
- Prior art date
Links
- 230000002195 synergetic effect Effects 0.000 title 1
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241000283086 Equidae Species 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 abstract 1
- 229960003184 carprofen Drugs 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68339105P | 2005-05-20 | 2005-05-20 | |
| PCT/IB2006/001655 WO2006123247A2 (en) | 2005-05-20 | 2006-05-18 | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20076463L true NO20076463L (no) | 2008-02-11 |
Family
ID=37102416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20076463A NO20076463L (no) | 2005-05-20 | 2007-12-14 | Synergetiske kombinasjoner |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080269310A1 (pt) |
| EP (1) | EP1940380A2 (pt) |
| JP (1) | JP2006328067A (pt) |
| KR (1) | KR20080003429A (pt) |
| CN (1) | CN101180045A (pt) |
| AR (1) | AR053733A1 (pt) |
| AU (1) | AU2006248645A1 (pt) |
| BR (1) | BRPI0610316A2 (pt) |
| CA (1) | CA2608010A1 (pt) |
| EA (1) | EA200702280A1 (pt) |
| IL (1) | IL187092A0 (pt) |
| MA (1) | MA29453B1 (pt) |
| MX (1) | MX2007014422A (pt) |
| NO (1) | NO20076463L (pt) |
| TN (1) | TNSN07430A1 (pt) |
| TW (1) | TW200724133A (pt) |
| WO (1) | WO2006123247A2 (pt) |
| ZA (1) | ZA200709830B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100491282B1 (ko) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| US9770440B2 (en) * | 2012-04-04 | 2017-09-26 | Intervet Inc. | Solid oral pharmaceutical compositions for isoxazoline compounds |
| PT3417862T (pt) * | 2012-07-27 | 2021-08-06 | Neurodyn Life Sciences Inc | Biodisponibilidade cerebral da galantamina melhorada através de formulações selecionadas e administração transmucosal de pró-fármacos lipofílicos |
| CN105431159B (zh) | 2013-05-14 | 2020-12-01 | 马斯公司 | 关节护理组合物 |
| GB201414910D0 (en) * | 2014-05-23 | 2014-10-08 | Mars Inc | Composition |
| CR20160573A (es) * | 2014-06-16 | 2017-03-14 | Farmacéuticos Rayere S A | Composición farmaceutica que combina un anticonvulsivante y un derivado del ácido nicotínico |
| MX2014008336A (es) | 2014-07-07 | 2016-01-07 | Pptm Internat S A R L | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
| MX378004B (es) | 2015-12-02 | 2025-03-10 | Jaime Samuel CHAIT AUERBACH | Composición oral veterinaria con gabapentina. |
| EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
| CN113444166A (zh) * | 2021-06-24 | 2021-09-28 | 深圳市疾病预防控制中心(深圳市卫生检验中心、深圳市预防医学研究所) | 卡洛芬人工抗原、抗体及其合成方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100491282B1 (ko) * | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| DZ2479A1 (fr) * | 1997-05-05 | 2003-02-01 | Pfizer | Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. |
-
2006
- 2006-05-18 KR KR1020077026847A patent/KR20080003429A/ko not_active Ceased
- 2006-05-18 MX MX2007014422A patent/MX2007014422A/es unknown
- 2006-05-18 EP EP06779735A patent/EP1940380A2/en not_active Withdrawn
- 2006-05-18 CN CNA2006800175067A patent/CN101180045A/zh active Pending
- 2006-05-18 US US11/914,825 patent/US20080269310A1/en not_active Abandoned
- 2006-05-18 WO PCT/IB2006/001655 patent/WO2006123247A2/en not_active Ceased
- 2006-05-18 CA CA002608010A patent/CA2608010A1/en not_active Abandoned
- 2006-05-18 BR BRPI0610316-2A patent/BRPI0610316A2/pt not_active IP Right Cessation
- 2006-05-18 AU AU2006248645A patent/AU2006248645A1/en not_active Abandoned
- 2006-05-18 EA EA200702280A patent/EA200702280A1/ru unknown
- 2006-05-19 JP JP2006140433A patent/JP2006328067A/ja active Pending
- 2006-05-19 TW TW095118032A patent/TW200724133A/zh unknown
- 2006-05-22 AR ARP060102091A patent/AR053733A1/es not_active Application Discontinuation
-
2007
- 2007-11-01 IL IL187092A patent/IL187092A0/en unknown
- 2007-11-14 ZA ZA200709830A patent/ZA200709830B/xx unknown
- 2007-11-19 TN TNP2007000430A patent/TNSN07430A1/fr unknown
- 2007-11-20 MA MA30381A patent/MA29453B1/fr unknown
- 2007-12-14 NO NO20076463A patent/NO20076463L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0610316A2 (pt) | 2010-06-15 |
| WO2006123247A2 (en) | 2006-11-23 |
| EP1940380A2 (en) | 2008-07-09 |
| JP2006328067A (ja) | 2006-12-07 |
| CA2608010A1 (en) | 2006-11-23 |
| KR20080003429A (ko) | 2008-01-07 |
| AU2006248645A1 (en) | 2006-11-23 |
| TW200724133A (en) | 2007-07-01 |
| ZA200709830B (en) | 2008-12-31 |
| US20080269310A1 (en) | 2008-10-30 |
| MA29453B1 (fr) | 2008-05-02 |
| TNSN07430A1 (fr) | 2009-03-17 |
| CN101180045A (zh) | 2008-05-14 |
| WO2006123247A3 (en) | 2007-04-26 |
| MX2007014422A (es) | 2008-02-11 |
| IL187092A0 (en) | 2008-06-05 |
| EA200702280A1 (ru) | 2008-04-28 |
| AR053733A1 (es) | 2007-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076463L (no) | Synergetiske kombinasjoner | |
| EA200970483A1 (ru) | Применение пролекарств габапентина и прегабалина для лечения шума в ушах | |
| EA200802184A1 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
| DK1957061T3 (da) | Kombination omfattende mindst én aminosyre og en PKR-inhibitor til anvendelse i behandlingen af muskelsvind | |
| BRPI0720500A8 (pt) | Preparação líquida transdérmica | |
| ATE502629T1 (de) | Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl) phenol und einem nsar | |
| PE20120074A1 (es) | Composicion que comprende cepa de bacillus subtilis para alimentar animales | |
| BRPI1009860A2 (pt) | composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais | |
| BR112013028435A2 (pt) | composição para aplicação transdérmica | |
| UA97795C2 (uk) | Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки | |
| WO2007135505A8 (en) | Veterinary pharmaceutical compositions for the treatment of pain and inflammation | |
| AR050783A1 (es) | Agentes terapeuticos con sal de nsaid y paracetamol | |
| CL2012003119A1 (es) | Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre. | |
| CY1115516T1 (el) | Φαρμακευτικη συνθεση που περιεχει ενα συνδυασμο ενος μη στεροειδικου αντιφλεγμονωδους παραγοντα και ενος αντισπασμωδικου παραγοντα | |
| CL2011001258A1 (es) | Sales de adicion de acido citrico de (r)-5-((e)-2-pirrolidin-3-il vinil)pirimidina; formas polimorficas monocitrato; composicion farmaceutica que las comprende; y su uso en la prevencion o en el tratamiento del dolor, inflamacion o un trastorno del sistema nervioso central. | |
| CR9200A (es) | Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos | |
| EA200900259A1 (ru) | Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением | |
| EA200500941A1 (ru) | Средство для лечения болезней суставов | |
| EA200500958A1 (ru) | Дейтерированные производные катехоламина, а также лекарственные средства, содержащие эти соединения | |
| EA200500942A1 (ru) | Средство для лечения болезней суставов | |
| NZ598124A (en) | Compounds for treatment of inflammation | |
| CR20120554A (es) | Combinación de un aine y un aminoácido | |
| CR20160021A (es) | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
| ES2545508T3 (es) | Uso de ácido benzoico o una sal del mismo para reducir trastornos del tracto urinario en rumiantes | |
| AR074674A1 (es) | Combinacion de sustancias activas mejorada que comprende un antibiotico y un farmaco antiinflamatorio no esteroideo (aine) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |